RhumbLine Advisers
ASXC

RhumbLine Advisers’s Asensus Surgical, Inc. ASXC Stock Holding History

RhumbLine Advisers’s Portfolio ASXC Stock Details ASXC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-218,056
Closed -$137K – 3270
2022
Q1 		$137K Sell
218,056
-40,417
-16% -$31.1K ﹤0.01% 2838
2021
Q4 		$287K Sell
258,473
-19,812
-7% -$30.6K ﹤0.01% 2721
2021
Q3 		$515K Buy
278,285
+54,389
+24% +$122K ﹤0.01% 2527
2021
Q2 		$710K Buy
+223,896
New +$560K ﹤0.01% 2405
2020
Q2 		– Sell
-19,417
Closed -$7K – 3126
2020
Q1 		$7K Buy
19,417
+3
+0% +$3 ﹤0.01% 2922
2019
Q4 		$29K Buy
19,414
+112
+0.6% +$389 ﹤0.01% 2934
2019
Q3 		$156K Buy
19,302
+513
+3% +$6.97K ﹤0.01% 2809
2019
Q2 		$332K Buy
18,789
+2,403
+15% +$52.6K ﹤0.01% 2565
2019
Q1 		$507K Buy
16,386
+163
+1% +$5.46K ﹤0.01% 2324
2018
Q4 		$477K Buy
16,223
+5,747
+55% +$261K ﹤0.01% 2318
2018
Q3 		$790K Sell
10,476
-500
-5% -$33.8K ﹤0.01% 2102
2018
Q2 		$622K Buy
+10,976
New +$400K ﹤0.01% 2217
2017
Q2 		– Sell
-4,618
Closed -$73K – 2965
2017
Q1 		$73K Buy
4,618
+251
+6% +$4.35K ﹤0.01% 2800
2016
Q4 		$74K Sell
4,367
-105
-2% -$2.15K ﹤0.01% 2811
2016
Q3 		$98K Buy
4,472
+146
+3% +$2.67K ﹤0.01% 2811
2016
Q2 		$69K Sell
4,326
-514
-11% -$16.1K ﹤0.01% 2949
2016
Q1 		$267K Buy
4,840
+442
+10% +$18.9K ﹤0.01% 2591
2015
Q4 		$142K Buy
4,398
+192
+5% +$6.18K ﹤0.01% 2892
2015
Q3 		$124K Buy
4,206
+1,004
+31% +$37.2K ﹤0.01% 2910
2015
Q2 		$125K Buy
3,202
+212
+7% +$9.77K ﹤0.01% 2982
2015
Q1 		$114K Buy
2,990
+244
+9% +$9.21K ﹤0.01% 2936
2014
Q4 		$104K Buy
2,746
+273
+11% +$11.3K ﹤0.01% 2955
2014
Q3 		$140K Buy
2,473
+27
+1% +$1.46K ﹤0.01% 2874
2014
Q2 		$160K Buy
+2,446
New +$141K ﹤0.01% 2913

Other funds holding ASXC

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
E
Ergoteles New York $68.2M AUM 36.16% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
SHI
SV Health Investors Boston, Massachusetts $32.3M AUM 20.15% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

RhumbLine Advisers's ASXC Position: Q2 2022 in Review

RhumbLine Advisers sold out of Asensus Surgical, Inc. (ASXC) in Q2 2022, closing a stake of 218,056 shares — an estimated $137K sold.

RhumbLine Advisers first reported a position in ASXC in Q2 2014 and held it in 24 quarters. The position peaked at $790K in Q3 2018. 91 funds tracked by Wall St. Rank hold ASXC as of Q2 2022.

  • RhumbLine Advisers reported no remaining Asensus Surgical, Inc. position as of Q2 2022 after selling out during the quarter.
  • RhumbLine Advisers sold 218,056 Asensus Surgical, Inc. shares in Q2 2022, an estimated $137K.
  • RhumbLine Advisers first reported a position in Asensus Surgical, Inc. in Q2 2014 and held it in 24 quarters.
  • RhumbLine Advisers's Asensus Surgical, Inc. position peaked at $790K in Q3 2018.
  • 91 funds tracked by Wall St. Rank held Asensus Surgical, Inc. as of Q2 2022.

Based on RhumbLine Advisers's 13F filing for Q2 2022, filed 11 Aug 2022.